3D InSight™ Therapeutic Modality Screening | 3d in vitro drug screening in oncology
Our single agent and combination 3D InSight™ Oncology platform for efficacy testing applications offers unparalleled efficiency to accelerate your oncology research
Our 3D InSight™ Oncology platform mimics the physiology and the heterogeneity of the tumor microenvironment and patient-specific characteristics, offering a reliable, accurate in vitro model to test your pipeline of innovative cancer therapeutics. Our 3D InSight™ Oncology platform allows you to get robust, reproducible, and physiologically relevant results for any therapeutic candidate in your discovery program with days to weeks turnaround times.
Why Therapeutic Modality Screening with InSphero?
We inspire researchers, worldwide, to reach their full potential so that life changing therapies can ultimately make it into the hands of patients.
The leading 3D tumor technology to answer your questions
Build the right genomically characterized tumor model to answer a specific biological question
Validate your targets in highly biologically relevant 3D tumor models
Our platform gives you the ability to understand target engagement and efficacy in the context of a physiologically relevant tumor microenvironment
Data you can trust for our crucial decisions
Make decisions about your oncology portfolio with data you can trust
Visualize the effect of different inter-cellular interactions in action
Change the composition of the tumor microtissue to understand the contribution of each cell type to therapeutic resistance
Our Process in 3d in vitro drug screening in oncology
Context of use
Identify the biological question that needs to be asked and build a relevant oncology model to address it
Fast, quick convenient turnaround times
Unlike in vivo pharmacology studies that can take months, our turnaround times range from days to five weeks
Multiplex endpoints for informative solutions
Impress with a comprehensive report
Our report gives you everything you need to present the results to your organization.
